Clinical rheumatology
-
Clinical rheumatology · May 2019
Multicenter Study Observational StudyPredictors of abatacept retention over 2 years in patients with rheumatoid arthritis: results from the real-world ACTION study.
Evaluate abatacept retention over 2 years in the AbataCepT In rOutiNe clinical practice (ACTION) study. ⋯ Abatacept initiation as earlier vs later line of therapy in RA may achieve higher 2-year retention rates. RF and anti-CCP seropositivity could predict increased abatacept retention, irrespective of treatment line.